Nov. 7, 2019: Zoledronic acid to prevent bone loss; bone benefits for older patients switching from TDF to TAF; periperhal artery disease among women; motor dysfunction and cognitive impairment.
How food insecurity feeds inflammation; racial disparities in HPV16 prevalence; how HIV meds affect pre-existing neurocognitive impairment; central nervous system inflammation in the setting of HIV treatment success.
People who started antiretroviral therapy (ART) within four months of HIV infection had lower HIV DNA molecular diversity in cerebrospinal fluid (CSF) than did people who started later.
No Difference in Neuropsychological Test Results Between Early and Delayed Treatment in START Substudy
Neuropsychological test results were similar for those who started antiretroviral therapy immediately and those who waited before starting, according to a substudy in the START study.